Search

everythinglearnresearchcommunity

for

Search:↓

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Misinformation about alopecia can lead to poor treatment, so it's important for healthcare professionals to correct myths.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Oral tofacitinib successfully treated total body hair loss in one patient.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Araliadiol may promote hair growth like minoxidil without being toxic.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Stress can cause early aging in certain skin cells, leading to problems with hair growth.

Male gender and family history predict alopecia areata recurrence.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.